Stelios Papadopoulos, Director at BIOGEN IDEC INC. (BIIB), sold 2,020 shares at $219.62 ($444K) on 2013-06-11, disclosed to the SEC on 2013-06-13.
Scheduled sale ($444k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| EXEL | SELL | 2024-05-22 | $240K | — | Filing → |
| EXEL | SELL | 2022-02-24 | $3.3M | — | Filing → |
| EXEL | SELL | 2021-05-13 | $911K | — | Filing → |